Skip to page content |

Tiscali Quicklinks. Please visit our Accessibility Page for a list of the Access Keys you can use to find your way around the site, skip directly to the main navigation, to the page content, or to more links within lifestyle.

Advertisement starts



Advertisement ends

Content Starts Here


Melleril (discontinued in the UK - June 2005)

Health and Nutrition > Medicines > M

Melleril (discontinued in the UK - June 2005)




How does it work?

Melleril contains the active ingredient thioridazine, which belongs to a group of medicines known as the phenothiazine antipsychotics. (NB. Thioridazine is also available without a brand name, ie as the generic medicine.) It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Thioridazine blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. This medicine is used to treat schizophrenia, only as a second line treatment if other medicines have failed.

What is it used for?

  • Schizophrenia
  • Warning!

  • This medicine may cause drowsiness. If affected do not drive or operate machinery. Alcohol should be avoided.
  • You should not suddenly stop taking this medicine unless your doctor tells you otherwise.
  • It is recommended that you receive regular eye examinations while you taking this medicine, as it can sometimes cause eye problems. Consult your doctor if you experience any disturbances in your vision while taking this medicine.
  • If you experience any signs of infection while taking this medicine, such as flu-like symptoms, high temperature (fever), sore throat or inflammation of the lining of the mouth (stomatitis), you should tell your doctor immediately.
  • The functioning of your heart should be tested with a heart monitoring trace (ECG) before starting this medicine. This should be repeated before any dose increases and at 6 monthly intervals once your dose is stabilised.
  • Regular blood tests to monitor liver function and levels of salts (electrolytes) and blood components should be performed while taking this medicine.
  • Use with caution in

  • Abnormal muscle weakness
  • Epilepsy
  • History of chronic constipation
  • History of closed angle glaucoma
  • History of difficulty passing urine (urinary retention)
  • History of enlarged prostate gland
  • History of raised pressure within the eye
  • Hypothyroidism
  • Kidney disease
  • Liver disease
  • Low body weight
  • Parkinson's disease
  • People whose blood pressure drops when moving from lying or sitting to standing, causing dizziness (postural hypotension)
  • Severe disease affecting the airways or lungs
  • Tumour of the adrenal gland (phaeochromocytoma)
  • Not to be used in

  • Abnormal heart rhythm seen on the heart monitoring trace (ECG) as a 'prolonged QT interval', or a family history of this
  • Allergy to phenothiazines such as chlorpromazine and prochlorperazine
  • Breastfeeding
  • Children
  • Dementia
  • Family history of sudden death
  • Heart disorders such as heart failure, angina, abnormal heart rhythm, slow heart rate, heart block or other heart disease
  • Hereditary deficiency of a compound in the liver (cytochrome P450 2D6 deficiency)
  • History of abnormal heart rhythms (ventricular arrhythmias or Torsade de Pointes)
  • History of serious blood disorders such as decreased blood cell production by the bone marrow
  • History of severe allergic reactions, including those to light (photosensitivity)
  • Imbalance of the salts in the blood, particularly low blood potassium levels (hypokalaemia) or low blood magnesium levels (hypomagnesemia)
  • Reduced awareness, slow reactions or drowsiness due to medicines or illness that reduce activity in the central nervous system
  • Stroke
  • Unresponsive unconscious states (comatose states)
  • This medicine should not be used if you are allergic to one or any of its ingredients. Please inform your doctor or pharmacist if you have previously experienced such an allergy. If you feel you have experienced an allergic reaction, stop using this medicine and inform your doctor or pharmacist immediately.

    Pregnancy and Breastfeeding

    Certain medicines should not be used during pregnancy or breastfeeding. However, other medicines may be safely used in pregnancy or breastfeeding providing the benefits to the mother outweigh the risks to the unborn baby. Always inform your doctor if you are pregnant or planning a pregnancy, before using any medicine.

  • The safety of this medicine for use during pregnancy has not been established. It is not recommended for use in pregnancy unless considered essential by your doctor. Seek medical advice from your doctor.
  • This medicine passes into breast milk and women taking this medicine should therefore not breastfeed. Seek medical advice from your doctor.
  • Label warnings

  • This medication may cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink.


  • Go To Next Page>>
    The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care or attention by a qualified practitioner. The materials in this web site cannot and should not be used as a basis for diagnosis or choice of treatment. Conditions for use

    Powered by netdoctor

    © Copyright 1998 - 2004 NetDoctor.co.uk - All rights reserved

    Health Search
    Search all
    Diseases
    Medicines
     
     
     
    Medicines By Alphabet
    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Health Search
    Search all
    Diseases
    Medicines
     
     

    Advertisement starts



    Advertisement ends

    Page Footer